Jacob Vincent Micallef - Aug 15, 2024 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role: Chief Scientific Officer
Signature: /s/ Jacob Vincent Micallef
Stock symbol: VNRX
Transactions as of: Aug 15, 2024
Transactions value $: $0
Form type: 4
Date filed: 8/16/2024, 04:05 PM
Previous filing: Jun 4, 2024
Next filing: Sep 4, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNRX	Common Stock	Award	$0	+13.8K	+4.6%	$0.00	313K	Aug 15, 2024	Direct	F1
holding	VNRX	Common Stock						55K	Aug 15, 2024	By Spouse
holding	VNRX	Common Stock						38.1K	Aug 15, 2024	By Borlaug Limited	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On Sept 28, 2023, the reporting person was awarded 55,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to Dec 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 13,750 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 4,583 units, 4,583 units, and 4,584 units on each of Sept 28, 2024, 2025 and 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in Jan 2024, the rights with respect to 23,375 RSUs subject to the award previously vested and remain subject to time-based vesting. The rights with respect to the remaining 17,875 RSUs did not vest and were cancelled on August 15, 2024.
F2	The shares of common stock are held directly by Borlaug Limited. The reporting person is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of common stock held by Borlaug Limited.

Content

On Sept 28, 2023, the reporting person was awarded 55,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to Dec 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 13,750 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 4,583 units, 4,583 units, and 4,584 units on each of Sept 28, 2024, 2025 and 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in Jan 2024, the rights with respect to 23,375 RSUs subject to the award previously vested and remain subject to time-based vesting. The rights with respect to the remaining 17,875 RSUs did not vest and were cancelled on August 15, 2024.

The shares of common stock are held directly by Borlaug Limited. The reporting person is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of common stock held by Borlaug Limited.